Second Stage organic infant formula is suitable for 6~12 months鈥� baby. It has higher protein levels infant formula, appropriate proportion of DHA, ARA and free nucleotides as well as a sufficient amount of iron.
Highlights
The global Second Stage Organic Infant Formula market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.
North American market for Second Stage Organic Infant Formula is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Second Stage Organic Infant Formula is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global manufacturers of Second Stage Organic Infant Formula include Abbott, HiPP, Holle, Bellamy, Topfer, The Hain Celestial Group, Nature One, Perrigo and Babybio, etc. in 2022, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Second Stage Organic Infant Formula, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Second Stage Organic Infant Formula.
The Second Stage Organic Infant Formula market size, estimations, and forecasts are provided in terms of sales volume (Kiloton) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Second Stage Organic Infant Formula market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Second Stage Organic Infant Formula manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.
By Company
Abbott
HiPP
Holle
Bellamy
Topfer
The Hain Celestial Group
Nature One
Perrigo
Babybio
Gittis
Humana
Bimbosan
Ausnutria
Nutribio
HealthyTimes
Arla
Yeeper
Wyeth
Kendamil
Nestle
Feihe
JUNLEBAO
YILI
BIOSTIME
Biobim
Segment by Type
Cow麓s Milk Formulas
Goat麓s Milk Formulas
Other
Segment by Application
Online
Offline
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Second Stage Organic Infant Formula manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Second Stage Organic Infant Formula in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Second Stage Organic Infant Formula Market Overview
1.1 Product Overview and Scope of Second Stage Organic Infant Formula
1.2 Second Stage Organic Infant Formula Segment by Type
1.2.1 Global Second Stage Organic Infant Formula Market Value Comparison by Type (2023-2029)
1.2.2 Cow麓s Milk Formulas
1.2.3 Goat麓s Milk Formulas
1.2.4 Other
1.3 Second Stage Organic Infant Formula Segment by Application
1.3.1 Global Second Stage Organic Infant Formula Market Value by Application: (2023-2029)
1.3.2 Online
1.3.3 Offline
1.4 Global Second Stage Organic Infant Formula Market Size Estimates and Forecasts
1.4.1 Global Second Stage Organic Infant Formula Revenue 2018-2029
1.4.2 Global Second Stage Organic Infant Formula Sales 2018-2029
1.4.3 Global Second Stage Organic Infant Formula Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Second Stage Organic Infant Formula Market Competition by Manufacturers
2.1 Global Second Stage Organic Infant Formula Sales Market Share by Manufacturers (2018-2023)
2.2 Global Second Stage Organic Infant Formula Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Second Stage Organic Infant Formula Average Price by Manufacturers (2018-2023)
2.4 Global Second Stage Organic Infant Formula Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Second Stage Organic Infant Formula, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Second Stage Organic Infant Formula, Product Type & Application
2.7 Second Stage Organic Infant Formula Market Competitive Situation and Trends
2.7.1 Second Stage Organic Infant Formula Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Second Stage Organic Infant Formula Players Market Share by Revenue
2.7.3 Global Second Stage Organic Infant Formula Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Second Stage Organic Infant Formula Retrospective Market Scenario by Region
3.1 Global Second Stage Organic Infant Formula Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Second Stage Organic Infant Formula Global Second Stage Organic Infant Formula Sales by Region: 2018-2029
3.2.1 Global Second Stage Organic Infant Formula Sales by Region: 2018-2023
3.2.2 Global Second Stage Organic Infant Formula Sales by Region: 2024-2029
3.3 Global Second Stage Organic Infant Formula Global Second Stage Organic Infant Formula Revenue by Region: 2018-2029
3.3.1 Global Second Stage Organic Infant Formula Revenue by Region: 2018-2023
3.3.2 Global Second Stage Organic Infant Formula Revenue by Region: 2024-2029
3.4 North America Second Stage Organic Infant Formula Market Facts & Figures by Country
3.4.1 North America Second Stage Organic Infant Formula Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Second Stage Organic Infant Formula Sales by Country (2018-2029)
3.4.3 North America Second Stage Organic Infant Formula Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Second Stage Organic Infant Formula Market Facts & Figures by Country
3.5.1 Europe Second Stage Organic Infant Formula Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Second Stage Organic Infant Formula Sales by Country (2018-2029)
3.5.3 Europe Second Stage Organic Infant Formula Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Second Stage Organic Infant Formula Market Facts & Figures by Country
3.6.1 Asia Pacific Second Stage Organic Infant Formula Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Second Stage Organic Infant Formula Sales by Country (2018-2029)
3.6.3 Asia Pacific Second Stage Organic Infant Formula Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Second Stage Organic Infant Formula Market Facts & Figures by Country
3.7.1 Latin America Second Stage Organic Infant Formula Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Second Stage Organic Infant Formula Sales by Country (2018-2029)
3.7.3 Latin America Second Stage Organic Infant Formula Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Second Stage Organic Infant Formula Market Facts & Figures by Country
3.8.1 Middle East and Africa Second Stage Organic Infant Formula Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Second Stage Organic Infant Formula Sales by Country (2018-2029)
3.8.3 Middle East and Africa Second Stage Organic Infant Formula Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Second Stage Organic Infant Formula Sales by Type (2018-2029)
4.1.1 Global Second Stage Organic Infant Formula Sales by Type (2018-2023)
4.1.2 Global Second Stage Organic Infant Formula Sales by Type (2024-2029)
4.1.3 Global Second Stage Organic Infant Formula Sales Market Share by Type (2018-2029)
4.2 Global Second Stage Organic Infant Formula Revenue by Type (2018-2029)
4.2.1 Global Second Stage Organic Infant Formula Revenue by Type (2018-2023)
4.2.2 Global Second Stage Organic Infant Formula Revenue by Type (2024-2029)
4.2.3 Global Second Stage Organic Infant Formula Revenue Market Share by Type (2018-2029)
4.3 Global Second Stage Organic Infant Formula Price by Type (2018-2029)
5 Segment by Application
5.1 Global Second Stage Organic Infant Formula Sales by Application (2018-2029)
5.1.1 Global Second Stage Organic Infant Formula Sales by Application (2018-2023)
5.1.2 Global Second Stage Organic Infant Formula Sales by Application (2024-2029)
5.1.3 Global Second Stage Organic Infant Formula Sales Market Share by Application (2018-2029)
5.2 Global Second Stage Organic Infant Formula Revenue by Application (2018-2029)
5.2.1 Global Second Stage Organic Infant Formula Revenue by Application (2018-2023)
5.2.2 Global Second Stage Organic Infant Formula Revenue by Application (2024-2029)
5.2.3 Global Second Stage Organic Infant Formula Revenue Market Share by Application (2018-2029)
5.3 Global Second Stage Organic Infant Formula Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Abbott
6.1.1 Abbott Corporation Information
6.1.2 Abbott Description and Business Overview
6.1.3 Abbott Second Stage Organic Infant Formula Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Abbott Second Stage Organic Infant Formula Product Portfolio
6.1.5 Abbott Recent Developments/Updates
6.2 HiPP
6.2.1 HiPP Corporation Information
6.2.2 HiPP Description and Business Overview
6.2.3 HiPP Second Stage Organic Infant Formula Sales, Revenue and Gross Margin (2018-2023)
6.2.4 HiPP Second Stage Organic Infant Formula Product Portfolio
6.2.5 HiPP Recent Developments/Updates
6.3 Holle
6.3.1 Holle Corporation Information
6.3.2 Holle Description and Business Overview
6.3.3 Holle Second Stage Organic Infant Formula Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Holle Second Stage Organic Infant Formula Product Portfolio
6.3.5 Holle Recent Developments/Updates
6.4 Bellamy
6.4.1 Bellamy Corporation Information
6.4.2 Bellamy Description and Business Overview
6.4.3 Bellamy Second Stage Organic Infant Formula Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Bellamy Second Stage Organic Infant Formula Product Portfolio
6.4.5 Bellamy Recent Developments/Updates
6.5 Topfer
6.5.1 Topfer Corporation Information
6.5.2 Topfer Description and Business Overview
6.5.3 Topfer Second Stage Organic Infant Formula Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Topfer Second Stage Organic Infant Formula Product Portfolio
6.5.5 Topfer Recent Developments/Updates
6.6 The Hain Celestial Group
6.6.1 The Hain Celestial Group Corporation Information
6.6.2 The Hain Celestial Group Description and Business Overview
6.6.3 The Hain Celestial Group Second Stage Organic Infant Formula Sales, Revenue and Gross Margin (2018-2023)
6.6.4 The Hain Celestial Group Second Stage Organic Infant Formula Product Portfolio
6.6.5 The Hain Celestial Group Recent Developments/Updates
6.7 Nature One
6.6.1 Nature One Corporation Information
6.6.2 Nature One Description and Business Overview
6.6.3 Nature One Second Stage Organic Infant Formula Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Nature One Second Stage Organic Infant Formula Product Portfolio
6.7.5 Nature One Recent Developments/Updates
6.8 Perrigo
6.8.1 Perrigo Corporation Information
6.8.2 Perrigo Description and Business Overview
6.8.3 Perrigo Second Stage Organic Infant Formula Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Perrigo Second Stage Organic Infant Formula Product Portfolio
6.8.5 Perrigo Recent Developments/Updates
6.9 Babybio
6.9.1 Babybio Corporation Information
6.9.2 Babybio Description and Business Overview
6.9.3 Babybio Second Stage Organic Infant Formula Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Babybio Second Stage Organic Infant Formula Product Portfolio
6.9.5 Babybio Recent Developments/Updates
6.10 Gittis
6.10.1 Gittis Corporation Information
6.10.2 Gittis Description and Business Overview
6.10.3 Gittis Second Stage Organic Infant Formula Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Gittis Second Stage Organic Infant Formula Product Portfolio
6.10.5 Gittis Recent Developments/Updates
6.11 Humana
6.11.1 Humana Corporation Information
6.11.2 Humana Second Stage Organic Infant Formula Description and Business Overview
6.11.3 Humana Second Stage Organic Infant Formula Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Humana Second Stage Organic Infant Formula Product Portfolio
6.11.5 Humana Recent Developments/Updates
6.12 Bimbosan
6.12.1 Bimbosan Corporation Information
6.12.2 Bimbosan Second Stage Organic Infant Formula Description and Business Overview
6.12.3 Bimbosan Second Stage Organic Infant Formula Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Bimbosan Second Stage Organic Infant Formula Product Portfolio
6.12.5 Bimbosan Recent Developments/Updates
6.13 Ausnutria
6.13.1 Ausnutria Corporation Information
6.13.2 Ausnutria Second Stage Organic Infant Formula Description and Business Overview
6.13.3 Ausnutria Second Stage Organic Infant Formula Sales, Revenue and Gross Margin (2018-2023)
6.13.4 Ausnutria Second Stage Organic Infant Formula Product Portfolio
6.13.5 Ausnutria Recent Developments/Updates
6.14 Nutribio
6.14.1 Nutribio Corporation Information
6.14.2 Nutribio Second Stage Organic Infant Formula Description and Business Overview
6.14.3 Nutribio Second Stage Organic Infant Formula Sales, Revenue and Gross Margin (2018-2023)
6.14.4 Nutribio Second Stage Organic Infant Formula Product Portfolio
6.14.5 Nutribio Recent Developments/Updates
6.15 HealthyTimes
6.15.1 HealthyTimes Corporation Information
6.15.2 HealthyTimes Second Stage Organic Infant Formula Description and Business Overview
6.15.3 HealthyTimes Second Stage Organic Infant Formula Sales, Revenue and Gross Margin (2018-2023)
6.15.4 HealthyTimes Second Stage Organic Infant Formula Product Portfolio
6.15.5 HealthyTimes Recent Developments/Updates
6.16 Arla
6.16.1 Arla Corporation Information
6.16.2 Arla Second Stage Organic Infant Formula Description and Business Overview
6.16.3 Arla Second Stage Organic Infant Formula Sales, Revenue and Gross Margin (2018-2023)
6.16.4 Arla Second Stage Organic Infant Formula Product Portfolio
6.16.5 Arla Recent Developments/Updates
6.17 Yeeper
6.17.1 Yeeper Corporation Information
6.17.2 Yeeper Second Stage Organic Infant Formula Description and Business Overview
6.17.3 Yeeper Second Stage Organic Infant Formula Sales, Revenue and Gross Margin (2018-2023)
6.17.4 Yeeper Second Stage Organic Infant Formula Product Portfolio
6.17.5 Yeeper Recent Developments/Updates
6.18 Wyeth
6.18.1 Wyeth Corporation Information
6.18.2 Wyeth Second Stage Organic Infant Formula Description and Business Overview
6.18.3 Wyeth Second Stage Organic Infant Formula Sales, Revenue and Gross Margin (2018-2023)
6.18.4 Wyeth Second Stage Organic Infant Formula Product Portfolio
6.18.5 Wyeth Recent Developments/Updates
6.19 Kendamil
6.19.1 Kendamil Corporation Information
6.19.2 Kendamil Second Stage Organic Infant Formula Description and Business Overview
6.19.3 Kendamil Second Stage Organic Infant Formula Sales, Revenue and Gross Margin (2018-2023)
6.19.4 Kendamil Second Stage Organic Infant Formula Product Portfolio
6.19.5 Kendamil Recent Developments/Updates
6.20 Nestle
6.20.1 Nestle Corporation Information
6.20.2 Nestle Second Stage Organic Infant Formula Description and Business Overview
6.20.3 Nestle Second Stage Organic Infant Formula Sales, Revenue and Gross Margin (2018-2023)
6.20.4 Nestle Second Stage Organic Infant Formula Product Portfolio
6.20.5 Nestle Recent Developments/Updates
6.21 Feihe
6.21.1 Feihe Corporation Information
6.21.2 Feihe Second Stage Organic Infant Formula Description and Business Overview
6.21.3 Feihe Second Stage Organic Infant Formula Sales, Revenue and Gross Margin (2018-2023)
6.21.4 Feihe Second Stage Organic Infant Formula Product Portfolio
6.21.5 Feihe Recent Developments/Updates
6.22 JUNLEBAO
6.22.1 JUNLEBAO Corporation Information
6.22.2 JUNLEBAO Second Stage Organic Infant Formula Description and Business Overview
6.22.3 JUNLEBAO Second Stage Organic Infant Formula Sales, Revenue and Gross Margin (2018-2023)
6.22.4 JUNLEBAO Second Stage Organic Infant Formula Product Portfolio
6.22.5 JUNLEBAO Recent Developments/Updates
6.23 YILI
6.23.1 YILI Corporation Information
6.23.2 YILI Second Stage Organic Infant Formula Description and Business Overview
6.23.3 YILI Second Stage Organic Infant Formula Sales, Revenue and Gross Margin (2018-2023)
6.23.4 YILI Second Stage Organic Infant Formula Product Portfolio
6.23.5 YILI Recent Developments/Updates
6.24 BIOSTIME
6.24.1 BIOSTIME Corporation Information
6.24.2 BIOSTIME Second Stage Organic Infant Formula Description and Business Overview
6.24.3 BIOSTIME Second Stage Organic Infant Formula Sales, Revenue and Gross Margin (2018-2023)
6.24.4 BIOSTIME Second Stage Organic Infant Formula Product Portfolio
6.24.5 BIOSTIME Recent Developments/Updates
6.25 Biobim
6.25.1 Biobim Corporation Information
6.25.2 Biobim Second Stage Organic Infant Formula Description and Business Overview
6.25.3 Biobim Second Stage Organic Infant Formula Sales, Revenue and Gross Margin (2018-2023)
6.25.4 Biobim Second Stage Organic Infant Formula Product Portfolio
6.25.5 Biobim Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Second Stage Organic Infant Formula Industry Chain Analysis
7.2 Second Stage Organic Infant Formula Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Second Stage Organic Infant Formula Production Mode & Process
7.4 Second Stage Organic Infant Formula Sales and Marketing
7.4.1 Second Stage Organic Infant Formula Sales Channels
7.4.2 Second Stage Organic Infant Formula Distributors
7.5 Second Stage Organic Infant Formula Customers
8 Second Stage Organic Infant Formula Market Dynamics
8.1 Second Stage Organic Infant Formula Industry Trends
8.2 Second Stage Organic Infant Formula Market Drivers
8.3 Second Stage Organic Infant Formula Market Challenges
8.4 Second Stage Organic Infant Formula Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Abbott
HiPP
Holle
Bellamy
Topfer
The Hain Celestial Group
Nature One
Perrigo
Babybio
Gittis
Humana
Bimbosan
Ausnutria
Nutribio
HealthyTimes
Arla
Yeeper
Wyeth
Kendamil
Nestle
Feihe
JUNLEBAO
YILI
BIOSTIME
Biobim
听
听
*If Applicable.